Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: A secondary analysis of the AVANT trial

by on 16 de novembre de 2020 with No hi ha comentaris
  • Chibaudel, B., Henriques, J., Rakez, M., Brenner, B., Kim, T. W., Martinez-Villacampa, M., . . . Tabernero, J., de Gramont, A. (2020). Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: A secondary analysis of the AVANT trial. JAMA Network Open, 3(10), e2020425. https://doi.org/10.1001/jamanetworkopen.2020.20425

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *